Acucela Appoints Robert “Bob” J. Stevens to its Board of Directors

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that it has appointed Robert “Bob” J. Stevens to its Board of Directors. “Bob’s 33 years of experience in the ophthalmology field will bring valuable perspectives to the Board and provide Acucela with a strong background in product research and design. His extensive work as a head of business development

Full Story →